Table 3.
Tfh cell responses in various vaccine candidates of SARS-CoV-2.
| Vaccine candidates | Phenotypes | Function | Antibody isotypes | References |
|---|---|---|---|---|
| mRNA vaccines | ||||
| mRNA-1273 | IL-21+CXCR5+PD−1+ICOS+Tfh cells expansion. | Induce robust and specific antibody responses including neutralizing antibody. | IgA, IgG | (166) |
| full SΔ furin mRNA | B220-CD4+CD44hiCD62L-CXCR5+Bcl-6+ Tfh cells, B220-CD4+CD44hiCXCR5+PD-1hi IL-21+Tfh cells, B220-CD4+CD44hiCXCR5+Bcl-6+ ICOS+Tfh cells B220-CD4+CD44hiCXCR5+PD-1hi IFN-γ+Tfh cells notable expansion. |
Elicit potent SARS-CoV-2-specific GC B responses, induce robust and specific antibody responses including neutralizing antibody. | IgG1, IgG2a, IgG2b, | (167) (167) |
| RBD mRNA (receptor binding domain, RBD) |
B220-CD4+CD44hiCD62L-CXCR5+Bcl-6+ Tfh cells, B220-CD4+CD44hiCXCR5+PD-1hi IL-21+Tfh cells, B220-CD4+CD44hiCXCR5+Bcl-6+ ICOS+Tfh cells, B220-CD4+CD44hiCXCR5+PD-1hi IFN-γ+Tfh cells notable expansion |
Elicit potent SARS-CoV-2-specific GC B responses, induce robust and specific antibody responses including neutralizing antibody. | IgG1, IgG2a, IgG2b, | |
| BNT162b2 mRNA vaccine | AIM+CXCR5+CD45RA-CD3+cTfh cells expansion, AIM cells include CD69+OX40+ or CD69+CD40L+ orCD69+4-1BB+ or OX40+4-1BB+ or CD40L+4-1BB+ or CD40L+OX40+ | Positively correlate with anti-spike-specific IgA and IgG titers. | IgA, IgG | (168) |
| Protein vaccines | ||||
| rRBD-AddaVax | B220-CD4+CD44hiCD62L-CXCR5+Bcl-6+ Tfh cells, B220-CD4+CD44hiCXCR5+PD-1hi IL-21+Tfh cells B220-CD4+CD44hiCXCR5+PD-1hi IL-4+Tfh cells slight expansion |
Delay to elicit potent SARS-CoV-2-specific GC B responses, induce robust and specific antibody responses including neutralizing antibody. | IgG1, | (167) |
| NVX-CoV2373 | CXCR5+PD-1+CD4+Tfh cells expansion | Induce specific antibody responses including neutralizing antibody. | IgG | (169) |
| Spike (S) and receptor binding domain (RBD) protein subunit vaccine | CXCR5++BCL-6+CD4+CD3+B220-Tfh cells expansion | Induce specific antibody responses including neutralizing antibody. | IgG | (170) |
| StriFK-FH002C | PD-1+CXCR5+CD4+Tfh cells expansion | Induce specific antibody responses including neutralizing antibody. | IgG, IgG1, IgG2a, IgG2b | (171) |
Tfh, follicular helper T cell; cTfh, circulating Tfh cell.